Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 9, 2022
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cellsRoberto Gedaly, Virgilius Cornea, Lilia Turcios, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
AIDS (London, England)|May 18, 2023
Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiationMathieu Chalouni, Adam Trickey, Suzanne M Ingle, et al.
Cancer Immunology Research|April 27, 2026
An ICAM1-targeting chimeric costimulatory receptor mimics the immune synapse and enhances tumor-specific T cell functionIrene M Min, Yanping Yang, Dessislava Stefanova, et al.
European Journal of Internal Medicine|April 28, 2021
Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot studyJuan Gonzalez Del Castillo, Carlota Clemente-Callejo, Ferran Llopis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel, José M Miró, Beatriz Mahillo, et al.
Journal of the International AIDS Society|September 10, 2020
Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort studyBeatriz Dominguez-Molina, Laura Tarancon-Diez, Yusnelkis Milanés-Guisado, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2008
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohortPere Domingo, Ignacio Suárez-Lozano, Ferran Torres, et al.
International Journal of Molecular Sciences|June 12, 2026
Mitigation of Ischemia-Reperfusion Injury and Improvement in Overall Graft Viability by Hypothermic Pulsatile Perfusion with Molecular Hydrogen Is Associated with Trx-1/HO-1 Activation in a Non-Survival Ex Vivo Swine Model of Donation-After-Circulatory-Death Kidney Preservation and TransplantationGeorge J Dugbartey, Cora England, Tamara S Ortas, et al.
Pageof 18